Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 comparison of oral NXL103 versus amoxicillin for adult community-acquired pneumonia
2007-001735-66Phase 2Completed
- Sponsor
- Novexel
- Start
- Jul 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of flopristin + linopristin and amoxicillin in community-acquired pneumonia (CAP) (3 arms), sponsored by Novexel. Started Jul 2007; status: completed.
02
Drugs
flopristin + linopristinamoxicillin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2007-001735-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001735-66.